Aurora Cannabis Inc.
TSX:ACB.TODrug Manufacturers - Specialty & Generic
+$0.02 today
- Market cap
- $414.85M
- Beta
- 1.34
- P/E (TTM)
- -3.2
- EPS (TTM)
- -$1.31
Volume 0.32M
Average 0.42M
ACB.TO Long-term Debt
Borrowings due after more than one year.
Aurora Cannabis Inc.TSX: ACB.TO
Long-term Debt · Q4 FY2026 · quarter ended Mar 2026
Long-term debt remains negative
Q4 FY2026 long-term debt was CA$0, compared with CA$40.19M a year earlier.
Context
- Long-term debt amounted to 0.0% of total assets at the end of Q4 FY2026, down 4.7 pp from a year earlier.
- Long-term debt increased in 1 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether long-term debt keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Debt history
CAD · from the balance sheet
- Latest · FY2026
- 0 CAD
- Year-over-year change
- -100.0%
| Period | Period end | Long-term Debt | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 0 | -100.0% |
| FY2025 | 2025-03-31 | 40.19M | -15.5% |
| FY2024 | 2024-03-31 | 47.57M | +31.6% |
| FY2023 | 2023-03-31 | 36.16M | -84.7% |
| FY2022 | 2022-06-30 | 236.49M | — |
Long-term Debt vs competitors
How ACB.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so long-term debt is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -100.0% is the 4th highest of 6, against a peer median of -27.6%.
- Long-term debt amounts to 0.0% of total assets for ACB.TO, versus a peer median of 13.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CA$217.12M CAD | -27.6% | -33.8% | 19.4% | |
| Mar 2026 | $212.15M USD | +10.0% | +12.6% | 38.6% | |
| Mar 2026 | CA$38.89M CAD | +1203.3% | -30.5% | 13.9% | |
| Mar 2026 | CA$4.51M CAD | — | +7.1% | 98.5% | |
| Mar 2026 | CA$0 CAD | -100.0% | — | 0.0% | |
| Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| Mar 2026 | CA$0 CAD | — | — | 0.0% | |
| Peer median (excluding ACB.TO) | — | -27.6% | -11.7% | 13.9% | |
Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jun 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 437.81M | 300.84M | 113.44M | 137.92M | 112.48M |
| Short-term Investments | 1.33M | 0 | 4.04M | 554K | 52.21M |
| Net Receivables | 47.05M | 41.35M | 45.41M | 42.47M | 44.58M |
| Inventory | 139.93M | 128.82M | 186.38M | 239.09M | 175.08M |
| Other Current Assets | 6.54M | 8.92M | 9.4M | 58.29M | 13.11M |
| Total Current Assets | 745.12M | 479.93M | 426.61M | 478.33M | 397.45M |
| Property, Plant & Equipment (Net) | 233.47M | 322.97M | 294.32M | 268.11M | 123.69M |
| Goodwill | 0 | 18.72M | 43.18M | 43.87M | 26.65M |
| Intangible Assets | 70.7M | 61.4M | 40.85M | 45.16M | 31.44M |
| Long-term Investments | 1.21M | 13.75M | 6.34M | 5.26M | 15.78M |
| Tax Assets | 0 | 15.5M | 15.34M | 4.22M | 2.46M |
| Other Non-current Assets | 33.87M | 14.06M | 12.03M | 12.98M | 3.62M |
| Total Non-current Assets | 339.24M | 446.4M | 412.07M | 374.34M | 203.63M |
| Total Assets | 1.08B | 926.32M | 838.67M | 852.67M | 601.09M |
| Account Payables | 13.86M | 21.94M | 20.33M | 27.62M | 9.31M |
| Short-term Debt | 33M | 147.56M | 57.22M | 21.51M | 5.73M |
| Tax Payables | 1.13M | 161K | 4.05M | 10.11M | 0 |
| Deferred Revenue | 3.85M | 1.74M | 1.69M | 1.07M | 1.27M |
| Other Current Liabilities | 80.66M | 49.13M | 25.07M | 1.69M | 44.93M |
| Total Current Liabilities | 145.23M | 242.31M | 124.62M | 110.86M | 66.93M |
| Long-term Debt | 236.49M | 36.16M | 47.57M | 40.19M | 0 |
| Deferred Tax Liabilities | 2.86M | 16.75M | 16.19M | 1.9M | 0 |
| Deferred Revenue (Non-current) | 37.3M | 43.8M | 2.31M | 0 | 0 |
| Other Non-current Liabilities | 128K | 70.17M | 46.11M | 53.63M | 4.19M |
| Total Non-current Liabilities | 276.77M | 166.88M | 112.18M | 133.21M | 22.32M |
| Total Liabilities | 422M | 409.19M | 236.8M | 244.08M | 89.26M |
| Common Stock | 6.75B | 6.84B | 6.97B | 6.99B | 7.01B |
| Retained Earnings | (6.04B) | (6.3B) | (6.37B) | (6.37B) | (6.44B) |
| Accumulated OCI | (54.51M) | (58.33M) | (43.71M) | (56.24M) | (53.49M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 6.95B |
| Minority Interest | 511K | 31.06M | 42.1M | 41.42M | 0 |
| Total Equity | 662.35M | 517.14M | 601.87M | 608.59M | 511.83M |
| Total Debt | 269.49M | 227.52M | 104.79M | 104.58M | 23.86M |
| Net Debt | (168.32M) | (73.32M) | (8.65M) | (33.34M) | (88.62M) |
Aurora Cannabis Inc.
TSX:ACB.TO
Intrinsic Alpha fair value
Locked
Current Price
$6.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.